glp-1 or metformin vs. Receptor Agonists: Which Diabetes Medication Is Right for You? Frontiers | Understanding the action

Subjects/Methods: Healthy pregnant women ( n =26) were randomly assigned in two groups receiving either a L-carnitine supplement (500 mg L-carnitine per day as L-carnitine L-tartrate) ( n =13) or placebo ( n =13) from the 13th week of gestation to term

10.1097/ALN.0b013e3181799d45 114 MassierL.ChakarounR.TabeiS.CraneA.DidtK

[5] A separate Bayesian network meta-analysis reached broadly consistent conclusions about retatrutides high placement for weight loss among incretin-based agents

The more significant weight loss observed with tirzepatide may be attributed to its dual action on both the GLP-1 and GIP receptors, whereas semaglutide targets only the GLP-1 receptor